Zoom Logo

FDA Science Board - Shared screen with speaker view - Recording 1/2
Gregory Gerdeman, Ph.D.
Please note that there is data emerging from a group called Physicians Research Center, studying adverse events from delta8-THC products. They are finding a higher incidence of AEs, especially respiratory AEs greater than anything seen with d9THC in state legal markets. This was presented at an FDA Listening Session by Teresa Simon in Oct 2021, and will be presented at the upcoming ICRS meeting in Ireland. Fantastic talk by Dr Peace... thank you!
Ryu Dojin
Thank you!